Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL191751 | 0.88 | — | — | |
| SCHEMBL12778798 | 0.87 | TSHR (0.41) | ALDH1A1FDPSTSHRTDP1 | |
| Water SCHEMBL26643057 | 0.85 | FDPS (0.39) | ALDH1A1FDPS | |
| SCHEMBL26103975 | 0.85 | FDPS (0.35) | ALDH1A1FDPS | |
| Ammonia Solution, Strong SCHEMBL2471319 | 0.85 | FDPS (0.39) | ALDH1A1FDPS | |
| SCHEMBL22032 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL28606232 | 0.82 | FDPS (0.38) | ALDH1A1FDPS | |
| SCHEMBL1674824 | 0.82 | — | — | |
| SCHEMBL12043115 | 0.82 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL309174 | 0.80 | FDPS (0.41) | ALDH1A1FDPSTSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10399931-B2 | Octahydroanthracene compound, preparation method and application thereof | SHANDONG XINHUA PHARMACEUTICAL CO., LTD. (CN) | 2019-09-03 | — | — | US | claimed |
| US-20190071393-A1 | Octahydroanthracene Compound, Preparation Method and Application Thereof | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2019-03-07 | — | — | US | claimed |
| US-20080293880-A1 | Liquid, Thermally Curable Mixtures, Their Preparation and Use | BASF COATINGS AG (DE) | 2008-11-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10399931-B2 | Octahydroanthracene compound, preparation method and application thereof | ODC1, OTC, TMT1A | ALDH1A1 152/4885FDPS 183/4885TSHR 2197/4885 |
| US-20190071393-A1 | Octahydroanthracene Compound, Preparation Method and Application Thereof | ODC1, OTC, TMT1A | ALDH1A1 152/4885FDPS 183/4885TSHR 2197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.